Propharm was officially inaugurated on Monday by the Prime Minister of Burkina Faso. It is the first generic drug manufacturing company in Burkina Faso.

The entirely private initiative, financed by Burkinabe and sub-regional capital, cost fifteen billion CFA francs. For the time being, it will manufacture three generic drugs, including paracetamol, and will eventually offer a dozen. The production capacity allows Propharm to consider supplying neighboring WAEMU countries.

The initiative for this government-supported project was taken by a group of professional pharmacists led by Palingwindé Armel Koéfé, Propharm's managing director. He explained to Olivier Rogez that the company was born out of a meeting between pharmacists and financiers. The production capacities allow Propharm to consider supplying neighboring countries of the Uemoa.